Author | Year | Research type | NOS or AHRQ score | Diagnostic criteria of PCOS | Gestational age | Primary study population | Type of cord blood | Testosterone | Androstenedione | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assay | Original unit | Assay | Original unit | ||||||||
Detti | 2019 | Cross-sectional | 8 | NIH criteria | term (≥38w) | PCOS vs non-PCOS women in labor | artery, vein | HPLC/MS | ng/dl | – | – |
Daan | 2017 | Case-control | 7 | Rotterdam criteria | not mentioned | PCOS vs non-PCOS women outpatients | mixed | LC-MS/MS | nmol/L | LC-MS/MS | nmol/L |
Caanen | 2016 | Case-control | 8 | Rotterdam criteria | not mentioned | PCOS vs non-PCOS in women a part of cohort study | mixed | LC-MS/MS | ng/ml | LC-MS/MS | ng/ml |
Maliqueo | 2013 | Case-control | 8 | NIH and Rotterdam criteria | term (37-40w) | PCOS outpatients vs healthy women in 12th week of gestation | mixed | RIA | ng/ml | RIA | ng/ml |
Mehrabian | 2012 | Cross-sectional | 9 | NIH criteria | term | PCOS vs healthy mothers who underwent elective cesarean section | mixed | CLIA | pg/ml | – | – |
Barry | 2010 | Case-control | 7 | Rotterdam criteria | ≥38w | PCOS vs non-PCOS women in labour wards | vein | ECL | nmol/L | – | – |
Anderson | 2010 | Case-control | 8 | NIH criteria | >35w | PCOS vs non-PCOS women outpatients | mixed | LC-MS | ng/dl | LC-MS | ng/dl |